CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Adamchak Mark Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +10,890 | 10,890 | ||
| 2026-02-02 | Dixon Jonathan V. GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +26,117 | 26,117 | ||
| 2026-02-02 | Chaubey Alka CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +27,737 | 27,737 | ||
| 2026-02-02 | OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Grant or award · Stock Option (Right to Buy) | +27,737 | 27,737 | ||
| 2026-02-02 | Holmlin R. Erik PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +69,484 | 69,484 | ||
| 2025-09-11 | Chaubey Alka Chief Medical Officer | Shares withheld for taxes | −51 | $4.06 | $207 | 662 |
| 2025-09-11 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −59 | $4.06 | $240 | 915 |
| 2025-09-11 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −59 | $4.06 | $240 | 915 |
| 2025-06-11 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-11 | Vuori Kristiina MD Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-11 | Linney Yvonne Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-11 | Luderer Albert Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-11 | BARKER DAVID L Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-11 | Mamuszka Hannah Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-11 | Rajkovic Aleksandar Director | Grant or award · Stock Option (Right to Buy) | +2,775 | 2,775 | ||
| 2025-06-03 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −27 | $3.69 | $100 | 974 |
| 2025-06-03 | Adamchak Mark Principal Accounting Officer | Shares withheld for taxes | −7 | $3.69 | $26 | 263 |
| 2025-06-03 | Chaubey Alka Chief Medical Officer | Shares withheld for taxes | −24 | $3.69 | $89 | 713 |
| 2025-06-03 | Holmlin R. Erik President and CEO | Shares withheld for taxes | −75 | $3.69 | $277 | 1,708 |
| 2025-06-03 | Dixon Jonathan V. General Counsel | Shares withheld for taxes | −25 | $3.69 | $92 | 269 |
Page 2 of 14 · 266 trades